Details for New Drug Application (NDA): 022445
✉ Email this page to a colleague
The generic ingredient in SUSTOL is granisetron. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the granisetron profile page.
Summary for 022445
Tradename: | SUSTOL |
Applicant: | Heron Theraps Inc |
Ingredient: | granisetron |
Patents: | 5 |
Pharmacology for NDA: 022445
Mechanism of Action | Serotonin 3 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 022445
Suppliers and Packaging for NDA: 022445
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445 | NDA | Heron Therapeutics, Inc. | 47426-101 | 47426-101-06 | 6 KIT in 1 CARTON (47426-101-06) / 1 SYRINGE, GLASS in 1 KIT / .4 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | 10MG/0.4ML (10MG/0.4ML) | ||||
Approval Date: | Aug 9, 2016 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 28, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | PROPHYLACTIC TREATMENT OF NAUSEA AND VOMITING, INCLUDING PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED CHEMOTHERAPY | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 28, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 28, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OR PREVENTION OF NAUSEA AND VOMITING |
Expired US Patents for NDA 022445
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | ⤷ Sign Up | ⤷ Sign Up |
Heron Theraps Inc | SUSTOL | granisetron | INJECTABLE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription